The economic footprint of the pharmaceutical industry
Related news and resources
Pharmaceutical industry calls on G7 to invest in innovation to drive competitiveness, resilience, and growth
IFPMA and Leem call on G7 leaders to place pharmaceutical innovation at the centre of their economic and competitiveness agenda.
Read more
UN Multi-Stakeholder Hearing on Pandemic Prevention, Preparedness, and Response (PPPR)
IFPMA statement at the UN Multi-Stakeholder Hearing on Pandemic Prevention, Preparedness, and Response (PPPR) in New York on 9 June. We share the same objective: a world better prepared to prevent, prepare for, detect, and respond to pandemics. Industry is a core part of that system, engaging in strengthening the health of populations, developing vaccines...
Read morePharmaceutical industry’s response to the Ebola Bundibugyo virus disease outbreak
The latest Ebola Bundibugyo outbreak in Democratic Republic of Congo, Uganda, and neighbouring countries is deeply concerning. Pharmaceutical and biotech companies are working with global partners in a coordinated response. Accelerating the response As the scientific, humanitarian, and global health response accelerates to contain the outbreak, pharmaceutical companies remain central to these efforts. While no...
Read more